Cargando…

Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11–7082, parthenolide and dimethyl fumarate

In mature erythrocytes, glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGDH) yield NADPH, a crucial cofactor of the enzyme glutathione reductase (GR) converting glutathione disulfide (GSSG) into its reduced state (GSH). GSH is essential for detoxification processes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghashghaeinia, Mehrdad, Giustarini, Daniela, Koralkova, Pavla, Köberle, Martin, Alzoubi, Kousi, Bissinger, Rosi, Hosseinzadeh, Zohreh, Dreischer, Peter, Bernhardt, Ingolf, Lang, Florian, Toulany, Mahmoud, Wieder, Thomas, Mojzikova, Renata, Rossi, Ranieri, Mrowietz, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926109/ https://www.ncbi.nlm.nih.gov/pubmed/27353740 http://dx.doi.org/10.1038/srep28754

Ejemplares similares

The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine –possible therapeutic implication
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020)

Association between nuclear factor of kappa B (NFκB) deficiency and induction of eryptosis in mouse erythrocytes
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020)

Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2019)

Desipramine induces eryptosis in human erythrocytes, an effect blunted by nitric oxide donor sodium nitroprusside and N-acetyl-L-cysteine but enhanced by Calcium depletion
por: Pan, Xia, et al.
Publicado: (2023)

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri
por: Debnath, Anjan, et al.
Publicado: (2018)

Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
por: Pustchi, Sadaf E., et al.
Publicado: (2020)

Effects of the NF-κB Signaling Pathway Inhibitor BAY11-7082 in the Replication of ASFV
por: Gao, Qi, et al.
Publicado: (2022)

BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple Targets
por: Lee, Jaehwi, et al.
Publicado: (2012)

Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082
por: Zhang, Lingyu, et al.
Publicado: (2019)

The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system
por: Strickson, Sam, et al.
Publicado: (2013)

Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion
por: Viola, K, et al.
Publicado: (2013)

The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
por: Hu, Shuiqing, et al.
Publicado: (2012)

The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2013)

Nuclear factor-κB inhibitor Bay11-7082 inhibits gastric cancer cell proliferation by inhibiting Gli1 expression
por: Yan, Yan, et al.
Publicado: (2021)

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway
por: Wang, Fang, et al.
Publicado: (2023)

Human erythrocytes, nuclear factor kappaB (NFκB) and hydrogen sulfide (H(2)S) – from non-genomic to genomic research
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2021)

Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB
por: Huang, Wei-Chieh, et al.
Publicado: (2022)

In Vivo Short-Term Topical Application of BAY 11-7082 Prevents the Acidic Bile–Induced mRNA and miRNA Oncogenic Phenotypes in Exposed Murine Hypopharyngeal Mucosa()()
por: Sasaki, Clarence T., et al.
Publicado: (2018)

Eryptosis: Programmed Death of Nucleus-Free, Iron-Filled Blood Cells
por: Dreischer, Peter, et al.
Publicado: (2022)

Inhibitor of IκB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells
por: Miyamoto, Rie, et al.
Publicado: (2010)

Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study
por: Falkvoll, Sandra, et al.
Publicado: (2019)

Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data
por: Landeck, Lilla, et al.
Publicado: (2018)

Two New Alkaloids from Fusarium tricinctum SYPF 7082, an Endophyte from the Root of Panax notoginseng
por: Sun, Wen-Jie, et al.
Publicado: (2018)

Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide
por: Lapcik, Petr, et al.
Publicado: (2023)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019)

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023)

Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide
por: Tiuman, Tatiana Shioji, et al.
Publicado: (2014)

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2015)

Parthenolide: a novel pharmacological approach to promote nerve regeneration
por: Diekmann, Heike, et al.
Publicado: (2016)

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017)

Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2020)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
por: Carlisi, Daniela, et al.
Publicado: (2022)

Bay11-7082 attenuates neuropathic pain via inhibition of nuclear factor-kappa B and nucleotide-binding domain-like receptor protein 3 inflammasome activation in dorsal root ganglions in a rat model of lumbar disc herniation
por: Zhang, Ailiang, et al.
Publicado: (2017)

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)

Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
por: Liu, Jun-Wei, et al.
Publicado: (2010)

Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
por: Liu, Man, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n7j79f28psde411egc02p91h5t